IDP-110

DRUG2 trials

Sponsors

Dow Pharmaceutical Sciences

Conditions

Acne Vulgaris

Phase 3

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

CompletedNCT00663286

Dow Pharmaceutical SciencesAcne Vulgaris

Start: 2006-10-31Updated: 2008-04-22

A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

CompletedNCT00664248

Dow Pharmaceutical SciencesAcne Vulgaris

Start: 2006-10-31Updated: 2008-04-22